A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened for cervical cancer.

HPV vaccination efforts have significantly reduced the rates of precancerous cervical lesions among women, particularly those aged 20-24, showing an 80% decrease. Continued screening and prevention are essential,

Because almost all cases of cervical cancer can be traced to HPV, some countries think the vaccine will help them eliminate the disease within years.

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human papillomavirus (HPV) vaccine. Rates of precancerous lesions in women between the ages of 20 and 24 dropped by roughly 80 percent from 2008 to 2022,

A new report published by the CDC shows how much the HPV vaccine has impacted cervical cancer. While there was a certain skepticism regarding its efficacy, this report proves how important it is to stay ahead of any future problems.

The human papillomavirus (HPV) vaccine is having a huge impact on cervical cancer prevention among young women, a U.S. government report published Thursday suggests. Why it matters: The CDC report shows that rates of precancerous lesions among women aged 20-24 screened for cervical cancer dropped by about 80% from 2008 to 2022.